{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"4"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"5"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"22"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"16"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"12"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"}],"title":"Very much worse"}],"title":"Symptom Burden"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"9"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"6"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"11"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"4"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"11"}],"title":"Very much worse"}],"title":"Impact on Worry/Mood"},{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"17"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"23"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"11"}],"title":"Very much worse"}],"title":"Impact on Daily Life"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"10"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"41"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"15"}],"title":"Very much worse"}],"title":"Body Image Problems"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"13"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"31"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"7"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"11"}],"title":"Very much worse"}],"title":"Satisfaction with Care and Information"},{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"14"}],"title":"Very much better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"Moderately better"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little better"},{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"37"}],"title":"Unchanged"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"A little worse"},{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"title":"Moderately worse"},{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"15"}],"title":"Very much worse"}],"title":"Satisfaction with Social Life"}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"66"}],"units":"Participants"}],"description":"The QLQ-CML24 consists of multi-scale items: symptom burden, impact on worry/mood, impact on daily life, body image problems, satisfaction with care and information and satisfaction with social life.\n\nA higher score on most of the item scales in QLQ-CML24 reflects a larger impairment in the corresponding domain, with the exception of the satisfaction with care and information, and problems and satisfaction with social life, where a higher score reflects a higher level of satisfaction.","groups":[{"description":"Patients took asciminib 80 mg QD under fasting conditions on ongoing basis.","id":"OG000","title":"Asciminib (All Asciminib)"},{"description":"Patients will take on ongoing basis the Investigator selected TKIs (imatinib, nilotinib, dasatinib or bosutinib)","id":"OG001","title":"Investigator Selected TKI (All Comparators)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Full Analysis Set: All participants who had an EORTC QLQ-CML24 assessment both at baseline and at week 48.","reportingStatus":"POSTED","timeFrame":"Baseline, week 48 and week 96.","title":"Change From Baseline in EORTC QLQ-CML24 Scales at Week 48 and Week 96","type":"SECONDARY","unitOfMeasure":"Participants"}